Point-of-care diagnostics for sepsis using clinical biomarkers and microfluidic technology

Sepsis is a life-threatening immune response which is caused by a wide variety of sources and is a leading cause of mortality globally. Rapid diagnosis and appropriate antibiotic treatment are critical for successful patient outcomes; however, current molecular diagnostic techniques are time-consuming, costly and require trained personnel. Additionally, there is a lack of rapid point-of-care (POC) devices available for sepsis detection despite the urgent requirements in emergency departments and low-resource areas. Recent advances have been made toward developing a POC test for early sepsis detection that will be more rapid and accurate compared to conventional techniques. Within this context, this review discusses the use of current and novel biomarkers for early sepsis diagnosis using microfluidics devices for POC testing.

Automated summary

Sepsis is a life-threatening immune response caused by various sources and is a major cause of global mortality. Current molecular diagnostic techniques for sepsis are time-consuming and require trained personnel, and there is a lack of rapid point-of-care (POC) devices for sepsis detection. This review explores the use of microfluidics devices for POC testing and the potential of current and novel biomarkers for early sepsis diagnosis, aiming to develop more rapid and accurate methods.